β-Adrenergic regulation of IL-6 release from adipose tissue: In vivo and in vitro studies
β-Adrenergic regulation of IL-6 release from adipose tissue: In vivo and in vitro studies
复制标题
DOI:
10.1210/jcem.86.12.8104
复制
发表时间:
2001-12
期刊:
影响因子:
--
通讯作者:
V. Mohamed-ali;L. Flower;Jaswinder K. Sethi;G. Hotamisligil;R. Gray;S. Humphries;D. York;J. Pinkney
中科院分区:
文献类型:
--
作者:
V. Mohamed-ali;L. Flower;Jaswinder K. Sethi;G. Hotamisligil;R. Gray;S. Humphries;D. York;J. Pinkney
Circulating IL-6 levels are elevated in obesity. Although IL-6 is expressed in adipose tissue, neither its regulation nor cell of origin is well characterized. Here we investigated the β-adrenergic regulation of IL-6 release in a combination of studies on humans and animals in vivo and cultured adipocytes in vitro. Human in vivo study: Human volunteers were infused with isoproterenol, norepinephrine, or saline {4 m:4F; mean (sd) age 35.5 (5.8) yr; body mass index 24.6 (4.2) kg/m−2}. Plasma IL-6 levels increased during a 3-h infusion of isoproterenol (P = 0.01) and fell 2 h post infusion (P = 0.05). IL-6 levels did not change significantly with either norepinephrine or saline. Murine in vivo study: C57BL6/J male mice were injected ip with dobutamine (β1 agonist), clenbuterol (β2), CL316243 (β3), or saline placebo. Plasma IL-6 levels at 3 h were increased by clenbuterol (P = 0.02) and CL316243 (P = 0.02) but not dobutamine (P = 0.51), compared with placebo. In vitro studies: In human peripheral blood cells,...